

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | chaperone-mediated protein transport (GO:0072321) | 5.89931342 |
| 2 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 5.32816310 |
| 3 | ribosomal small subunit assembly (GO:0000028) | 5.08977326 |
| 4 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 4.44220539 |
| 5 | DNA deamination (GO:0045006) | 4.43129271 |
| 6 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.26978107 |
| 7 | protein targeting to mitochondrion (GO:0006626) | 4.20785997 |
| 8 | oxidative phosphorylation (GO:0006119) | 4.20465762 |
| 9 | ATP synthesis coupled proton transport (GO:0015986) | 4.08896346 |
| 10 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.08896346 |
| 11 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.02194898 |
| 12 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.96881058 |
| 13 | ribosomal small subunit biogenesis (GO:0042274) | 3.96578585 |
| 14 | heme biosynthetic process (GO:0006783) | 3.93479077 |
| 15 | establishment of integrated proviral latency (GO:0075713) | 3.91930468 |
| 16 | rRNA modification (GO:0000154) | 3.90780887 |
| 17 | pseudouridine synthesis (GO:0001522) | 3.87243015 |
| 18 | respiratory electron transport chain (GO:0022904) | 3.85653053 |
| 19 | establishment of protein localization to mitochondrion (GO:0072655) | 3.85240748 |
| 20 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.82356931 |
| 21 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.81238195 |
| 22 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.81238195 |
| 23 | viral transcription (GO:0019083) | 3.80161174 |
| 24 | protein localization to mitochondrion (GO:0070585) | 3.78184497 |
| 25 | electron transport chain (GO:0022900) | 3.75315982 |
| 26 | chromatin remodeling at centromere (GO:0031055) | 3.74591450 |
| 27 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.74572178 |
| 28 | protein neddylation (GO:0045116) | 3.71661187 |
| 29 | CENP-A containing nucleosome assembly (GO:0034080) | 3.70777121 |
| 30 | translational termination (GO:0006415) | 3.66983580 |
| 31 | spliceosomal snRNP assembly (GO:0000387) | 3.65656503 |
| 32 | positive regulation of ligase activity (GO:0051351) | 3.65357294 |
| 33 | heme metabolic process (GO:0042168) | 3.64156024 |
| 34 | aldehyde catabolic process (GO:0046185) | 3.63519293 |
| 35 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.63158564 |
| 36 | establishment of viral latency (GO:0019043) | 3.56692155 |
| 37 | L-phenylalanine metabolic process (GO:0006558) | 3.53369826 |
| 38 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.53369826 |
| 39 | DNA replication checkpoint (GO:0000076) | 3.48675436 |
| 40 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.47692075 |
| 41 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.47467869 |
| 42 | rRNA processing (GO:0006364) | 3.47271417 |
| 43 | protein maturation by protein folding (GO:0022417) | 3.46164075 |
| 44 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.46108442 |
| 45 | cullin deneddylation (GO:0010388) | 3.45953486 |
| 46 | proteasome assembly (GO:0043248) | 3.44102304 |
| 47 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.42887392 |
| 48 | regulation of mitochondrial translation (GO:0070129) | 3.40466786 |
| 49 | ribosome assembly (GO:0042255) | 3.35346545 |
| 50 | protein deneddylation (GO:0000338) | 3.35074731 |
| 51 | regulation of ligase activity (GO:0051340) | 3.34854294 |
| 52 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.34264393 |
| 53 | DNA damage response, detection of DNA damage (GO:0042769) | 3.32284429 |
| 54 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.32032794 |
| 55 | cotranslational protein targeting to membrane (GO:0006613) | 3.31255804 |
| 56 | protein targeting to ER (GO:0045047) | 3.30806864 |
| 57 | rRNA metabolic process (GO:0016072) | 3.30569341 |
| 58 | translational elongation (GO:0006414) | 3.30479371 |
| 59 | respiratory chain complex IV assembly (GO:0008535) | 3.25979398 |
| 60 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.23815879 |
| 61 | L-phenylalanine catabolic process (GO:0006559) | 3.23815879 |
| 62 | DNA strand elongation (GO:0022616) | 3.22958140 |
| 63 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.21791860 |
| 64 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.21791860 |
| 65 | NADH dehydrogenase complex assembly (GO:0010257) | 3.21791860 |
| 66 | inner mitochondrial membrane organization (GO:0007007) | 3.21564315 |
| 67 | protein complex biogenesis (GO:0070271) | 3.21003716 |
| 68 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.20563873 |
| 69 | protein localization to endoplasmic reticulum (GO:0070972) | 3.20219859 |
| 70 | regulation of cellular amine metabolic process (GO:0033238) | 3.18974932 |
| 71 | mitotic metaphase plate congression (GO:0007080) | 3.18605626 |
| 72 | GTP biosynthetic process (GO:0006183) | 3.18313099 |
| 73 | 7-methylguanosine mRNA capping (GO:0006370) | 3.18197743 |
| 74 | kinetochore assembly (GO:0051382) | 3.17682808 |
| 75 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.17238764 |
| 76 | formation of translation preinitiation complex (GO:0001731) | 3.16585092 |
| 77 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.15866179 |
| 78 | ATP biosynthetic process (GO:0006754) | 3.15093467 |
| 79 | mitochondrial transport (GO:0006839) | 3.15007498 |
| 80 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.13679413 |
| 81 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.12861070 |
| 82 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.12861070 |
| 83 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.10631804 |
| 84 | glyoxylate metabolic process (GO:0046487) | 3.10300743 |
| 85 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.08239085 |
| 86 | aromatic amino acid family catabolic process (GO:0009074) | 3.08091936 |
| 87 | porphyrin-containing compound biosynthetic process (GO:0006779) | 3.06607723 |
| 88 | indole-containing compound catabolic process (GO:0042436) | 3.01038978 |
| 89 | indolalkylamine catabolic process (GO:0046218) | 3.01038978 |
| 90 | tryptophan catabolic process (GO:0006569) | 3.01038978 |
| 91 | cytochrome complex assembly (GO:0017004) | 3.00538420 |
| 92 | ribosomal large subunit biogenesis (GO:0042273) | 2.97511878 |
| 93 | viral life cycle (GO:0019058) | 2.95721979 |
| 94 | * translation (GO:0006412) | 2.93684338 |
| 95 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.89720940 |
| 96 | maturation of SSU-rRNA (GO:0030490) | 2.89279961 |
| 97 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.86901695 |
| 98 | cellular protein complex disassembly (GO:0043624) | 2.86826252 |
| 99 | porphyrin-containing compound metabolic process (GO:0006778) | 2.85421863 |
| 100 | amino acid salvage (GO:0043102) | 2.85361847 |
| 101 | L-methionine salvage (GO:0071267) | 2.85361847 |
| 102 | L-methionine biosynthetic process (GO:0071265) | 2.85361847 |
| 103 | tetrapyrrole biosynthetic process (GO:0033014) | 2.82758996 |
| 104 | tryptophan metabolic process (GO:0006568) | 2.82117889 |
| 105 | aerobic respiration (GO:0009060) | 2.79333949 |
| 106 | glycine metabolic process (GO:0006544) | 2.77600781 |
| 107 | branched-chain amino acid catabolic process (GO:0009083) | 2.76499250 |
| 108 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.76412746 |
| 109 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.76091961 |
| 110 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.75545227 |
| 111 | translational initiation (GO:0006413) | 2.75254867 |
| 112 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.73373870 |
| 113 | cellular ketone body metabolic process (GO:0046950) | 2.73087790 |
| 114 | kynurenine metabolic process (GO:0070189) | 2.69760905 |
| 115 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.65097828 |
| 116 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.63808355 |
| 117 | ubiquinone biosynthetic process (GO:0006744) | 2.62434826 |
| 118 | quinone biosynthetic process (GO:1901663) | 2.62434826 |
| 119 | iron-sulfur cluster assembly (GO:0016226) | 2.61926656 |
| 120 | metallo-sulfur cluster assembly (GO:0031163) | 2.61926656 |
| 121 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.61014567 |
| 122 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.61014567 |
| 123 | lysine catabolic process (GO:0006554) | 2.60934212 |
| 124 | lysine metabolic process (GO:0006553) | 2.60934212 |
| 125 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.58788863 |
| 126 | sulfur amino acid catabolic process (GO:0000098) | 2.57594818 |
| 127 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.57123486 |
| 128 | cofactor catabolic process (GO:0051187) | 2.56987799 |
| 129 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.56298156 |
| 130 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.55170469 |
| 131 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.55114470 |
| 132 | termination of RNA polymerase III transcription (GO:0006386) | 2.53587998 |
| 133 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.53587998 |
| 134 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.53286875 |
| 135 | negative regulation of ligase activity (GO:0051352) | 2.53286875 |
| 136 | regulation of cholesterol esterification (GO:0010872) | 2.53190756 |
| 137 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.51550566 |
| 138 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.51550566 |
| 139 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.50750398 |
| 140 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.50750398 |
| 141 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.50750398 |
| 142 | regulation of oxidative phosphorylation (GO:0002082) | 2.50258653 |
| 143 | cysteine metabolic process (GO:0006534) | 2.49444257 |
| 144 | cellular component biogenesis (GO:0044085) | 2.48920291 |
| 145 | serine family amino acid catabolic process (GO:0009071) | 2.48646102 |
| 146 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.48639966 |
| 147 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.48361859 |
| 148 | serine family amino acid biosynthetic process (GO:0009070) | 2.48043648 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.07966616 |
| 2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.86675823 |
| 3 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.63644233 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.59892701 |
| 5 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.28348400 |
| 6 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.23756156 |
| 7 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.16116053 |
| 8 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.15086932 |
| 9 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.09794503 |
| 10 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.94054326 |
| 11 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.90775271 |
| 12 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.78559717 |
| 13 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.77854943 |
| 14 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.72603504 |
| 15 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.60268269 |
| 16 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.58426053 |
| 17 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.56166149 |
| 18 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.50467257 |
| 19 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.49546643 |
| 20 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.47939610 |
| 21 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.29275602 |
| 22 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.22436606 |
| 23 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.21611748 |
| 24 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.19963972 |
| 25 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.08982470 |
| 26 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.06455333 |
| 27 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.02986442 |
| 28 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.97984038 |
| 29 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.96284439 |
| 30 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.96278006 |
| 31 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.94150748 |
| 32 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.91341837 |
| 33 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.89332337 |
| 34 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.87041639 |
| 35 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.86787676 |
| 36 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.86335864 |
| 37 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.84235988 |
| 38 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.78114353 |
| 39 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.76054986 |
| 40 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.73330384 |
| 41 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.72450608 |
| 42 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.70894402 |
| 43 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69623599 |
| 44 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.65672901 |
| 45 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.64631398 |
| 46 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.63096270 |
| 47 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.62125650 |
| 48 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.61820580 |
| 49 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.59390912 |
| 50 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.57734302 |
| 51 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.57692282 |
| 52 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.57071431 |
| 53 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.53122090 |
| 54 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.48418887 |
| 55 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.43961179 |
| 56 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.42543886 |
| 57 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.40629408 |
| 58 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.40544963 |
| 59 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.38952630 |
| 60 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.36226361 |
| 61 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.36181374 |
| 62 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.34666178 |
| 63 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.31878820 |
| 64 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.31251382 |
| 65 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.31223514 |
| 66 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.31051238 |
| 67 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.30597156 |
| 68 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.28950630 |
| 69 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.27374024 |
| 70 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.26710715 |
| 71 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.20617506 |
| 72 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.19902761 |
| 73 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.19884341 |
| 74 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.18381878 |
| 75 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.17748250 |
| 76 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.14392271 |
| 77 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13552792 |
| 78 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.12071354 |
| 79 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.11230073 |
| 80 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.10525090 |
| 81 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09866311 |
| 82 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.09424460 |
| 83 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.09280618 |
| 84 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.07036137 |
| 85 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.05948776 |
| 86 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.03302219 |
| 87 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.03089161 |
| 88 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.02047049 |
| 89 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.01480518 |
| 90 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.00951338 |
| 91 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.98418122 |
| 92 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.97811392 |
| 93 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.97566619 |
| 94 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.96862762 |
| 95 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.95859651 |
| 96 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.93906761 |
| 97 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.93072989 |
| 98 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.91771738 |
| 99 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.91132058 |
| 100 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.90873575 |
| 101 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.89339926 |
| 102 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.88838949 |
| 103 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.88081861 |
| 104 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.87798475 |
| 105 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.87510695 |
| 106 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.86405395 |
| 107 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.85262486 |
| 108 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.84953869 |
| 109 | GATA1_22025678_ChIP-Seq_K562_Human | 0.84170048 |
| 110 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.83988098 |
| 111 | * SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.83499852 |
| 112 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.81838295 |
| 113 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.81712292 |
| 114 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.81468591 |
| 115 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.81264513 |
| 116 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.80898959 |
| 117 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.80244947 |
| 118 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.79048625 |
| 119 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.78792872 |
| 120 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.78489567 |
| 121 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.78353192 |
| 122 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.77391007 |
| 123 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.76181143 |
| 124 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.71948103 |
| 125 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.71206127 |
| 126 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.69277168 |
| 127 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.69219665 |
| 128 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.65838317 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.38999022 |
| 2 | MP0003806_abnormal_nucleotide_metabolis | 4.32405501 |
| 3 | MP0005360_urolithiasis | 4.23841056 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.50995731 |
| 5 | MP0005365_abnormal_bile_salt | 3.06197322 |
| 6 | MP0003186_abnormal_redox_activity | 2.94397038 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 2.93829291 |
| 8 | MP0008932_abnormal_embryonic_tissue | 2.87441262 |
| 9 | MP0009379_abnormal_foot_pigmentation | 2.83594288 |
| 10 | MP0006036_abnormal_mitochondrial_physio | 2.67980782 |
| 11 | MP0009840_abnormal_foam_cell | 2.67905640 |
| 12 | MP0000372_irregular_coat_pigmentation | 2.62649085 |
| 13 | MP0006292_abnormal_olfactory_placode | 2.51484064 |
| 14 | MP0003693_abnormal_embryo_hatching | 2.44868229 |
| 15 | MP0002938_white_spotting | 2.30248646 |
| 16 | MP0003195_calcinosis | 2.28305770 |
| 17 | MP0003646_muscle_fatigue | 2.25274765 |
| 18 | MP0010030_abnormal_orbit_morphology | 2.16285126 |
| 19 | MP0003123_paternal_imprinting | 2.14568553 |
| 20 | MP0005332_abnormal_amino_acid | 2.05577868 |
| 21 | MP0003941_abnormal_skin_development | 2.00165631 |
| 22 | MP0001764_abnormal_homeostasis | 1.96595600 |
| 23 | MP0001835_abnormal_antigen_presentation | 1.92320933 |
| 24 | MP0003191_abnormal_cellular_cholesterol | 1.86171662 |
| 25 | MP0003656_abnormal_erythrocyte_physiolo | 1.85780833 |
| 26 | MP0002132_abnormal_respiratory_system | 1.82908424 |
| 27 | MP0005083_abnormal_biliary_tract | 1.71897275 |
| 28 | MP0003252_abnormal_bile_duct | 1.70117741 |
| 29 | MP0005319_abnormal_enzyme/_coenzyme | 1.69665052 |
| 30 | MP0005451_abnormal_body_composition | 1.69257806 |
| 31 | MP0009785_altered_susceptibility_to | 1.65793774 |
| 32 | MP0009697_abnormal_copulation | 1.62860112 |
| 33 | MP0010329_abnormal_lipoprotein_level | 1.62058760 |
| 34 | MP0001529_abnormal_vocalization | 1.55986307 |
| 35 | MP0002102_abnormal_ear_morphology | 1.52339856 |
| 36 | MP0002163_abnormal_gland_morphology | 1.51571951 |
| 37 | MP0006035_abnormal_mitochondrial_morpho | 1.51479394 |
| 38 | MP0002138_abnormal_hepatobiliary_system | 1.50224140 |
| 39 | MP0001293_anophthalmia | 1.45164407 |
| 40 | MP0004019_abnormal_vitamin_homeostasis | 1.44719515 |
| 41 | MP0000358_abnormal_cell_content/ | 1.43332847 |
| 42 | MP0002837_dystrophic_cardiac_calcinosis | 1.43318359 |
| 43 | MP0001853_heart_inflammation | 1.42428309 |
| 44 | MP0001666_abnormal_nutrient_absorption | 1.39894186 |
| 45 | MP0009643_abnormal_urine_homeostasis | 1.37011696 |
| 46 | MP0000609_abnormal_liver_physiology | 1.36509279 |
| 47 | MP0004147_increased_porphyrin_level | 1.35575561 |
| 48 | MP0000350_abnormal_cell_proliferation | 1.33599449 |
| 49 | MP0008789_abnormal_olfactory_epithelium | 1.32373475 |
| 50 | MP0002148_abnormal_hypersensitivity_rea | 1.31862787 |
| 51 | MP0004957_abnormal_blastocyst_morpholog | 1.31666826 |
| 52 | MP0008469_abnormal_protein_level | 1.28798837 |
| 53 | MP0003718_maternal_effect | 1.28510333 |
| 54 | MP0000749_muscle_degeneration | 1.27934811 |
| 55 | MP0003724_increased_susceptibility_to | 1.27889594 |
| 56 | MP0003436_decreased_susceptibility_to | 1.27444835 |
| 57 | MP0002277_abnormal_respiratory_mucosa | 1.24149124 |
| 58 | MP0005636_abnormal_mineral_homeostasis | 1.22400496 |
| 59 | MP0009764_decreased_sensitivity_to | 1.22007144 |
| 60 | MP0003315_abnormal_perineum_morphology | 1.21346775 |
| 61 | MP0004782_abnormal_surfactant_physiolog | 1.21281166 |
| 62 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.20261096 |
| 63 | MP0001730_embryonic_growth_arrest | 1.17875903 |
| 64 | MP0002160_abnormal_reproductive_system | 1.17292527 |
| 65 | MP0001697_abnormal_embryo_size | 1.15582051 |
| 66 | MP0008058_abnormal_DNA_repair | 1.14888711 |
| 67 | MP0005266_abnormal_metabolism | 1.14685978 |
| 68 | MP0005330_cardiomyopathy | 1.14571587 |
| 69 | MP0000566_synostosis | 1.14457291 |
| 70 | MP0005408_hypopigmentation | 1.13429670 |
| 71 | MP0000490_abnormal_crypts_of | 1.12856457 |
| 72 | MP0005025_abnormal_response_to | 1.09564629 |
| 73 | MP0000313_abnormal_cell_death | 1.09290436 |
| 74 | MP0003011_delayed_dark_adaptation | 1.09192079 |
| 75 | MP0000685_abnormal_immune_system | 1.07299060 |
| 76 | MP0006072_abnormal_retinal_apoptosis | 1.05292294 |
| 77 | MP0005084_abnormal_gallbladder_morpholo | 1.05271654 |
| 78 | MP0003950_abnormal_plasma_membrane | 1.03718745 |
| 79 | MP0005376_homeostasis/metabolism_phenot | 1.03624183 |
| 80 | MP0005670_abnormal_white_adipose | 1.01081679 |
| 81 | MP0002118_abnormal_lipid_homeostasis | 1.00941524 |
| 82 | MP0003077_abnormal_cell_cycle | 1.00691841 |
| 83 | MP0001881_abnormal_mammary_gland | 1.00150608 |
| 84 | MP0002396_abnormal_hematopoietic_system | 1.00103742 |
| 85 | MP0002210_abnormal_sex_determination | 1.00028258 |
| 86 | MP0000343_altered_response_to | 0.98916625 |
| 87 | MP0003567_abnormal_fetal_cardiomyocyte | 0.97666035 |
| 88 | MP0000750_abnormal_muscle_regeneration | 0.97401080 |
| 89 | MP0001905_abnormal_dopamine_level | 0.95485123 |
| 90 | MP0000598_abnormal_liver_morphology | 0.95254884 |
| 91 | MP0003136_yellow_coat_color | 0.94840680 |
| 92 | MP0009763_increased_sensitivity_to | 0.94464994 |
| 93 | MP0009333_abnormal_splenocyte_physiolog | 0.94268002 |
| 94 | MP0010094_abnormal_chromosome_stability | 0.93551794 |
| 95 | MP0003221_abnormal_cardiomyocyte_apopto | 0.92116562 |
| 96 | MP0002876_abnormal_thyroid_physiology | 0.90714983 |
| 97 | MP0000049_abnormal_middle_ear | 0.89525440 |
| 98 | MP0002419_abnormal_innate_immunity | 0.88129932 |
| 99 | MP0003111_abnormal_nucleus_morphology | 0.88078212 |
| 100 | MP0008007_abnormal_cellular_replicative | 0.87846039 |
| 101 | MP0001756_abnormal_urination | 0.86222012 |
| 102 | MP0001727_abnormal_embryo_implantation | 0.85970009 |
| 103 | MP0002080_prenatal_lethality | 0.85813956 |
| 104 | MP0005389_reproductive_system_phenotype | 0.85066293 |
| 105 | MP0001672_abnormal_embryogenesis/_devel | 0.83656379 |
| 106 | MP0005380_embryogenesis_phenotype | 0.83656379 |
| 107 | MP0008995_early_reproductive_senescence | 0.83488352 |
| 108 | MP0002095_abnormal_skin_pigmentation | 0.82963122 |
| 109 | MP0001845_abnormal_inflammatory_respons | 0.82669581 |
| 110 | MP0003786_premature_aging | 0.82024499 |
| 111 | MP0005671_abnormal_response_to | 0.80118378 |
| 112 | MP0009642_abnormal_blood_homeostasis | 0.78898604 |
| 113 | MP0005464_abnormal_platelet_physiology | 0.78670884 |
| 114 | MP0004145_abnormal_muscle_electrophysio | 0.78572731 |
| 115 | MP0001929_abnormal_gametogenesis | 0.78511814 |
| 116 | MP0006082_CNS_inflammation | 0.77846270 |
| 117 | MP0002085_abnormal_embryonic_tissue | 0.77208022 |
| 118 | MP0010155_abnormal_intestine_physiology | 0.76653560 |
| 119 | MP0001542_abnormal_bone_strength | 0.75402489 |
| 120 | MP0001145_abnormal_male_reproductive | 0.74872527 |
| 121 | MP0005379_endocrine/exocrine_gland_phen | 0.74794443 |
| 122 | MP0005000_abnormal_immune_tolerance | 0.74409245 |
| 123 | MP0002090_abnormal_vision | 0.73846950 |
| 124 | MP0001663_abnormal_digestive_system | 0.72856828 |
| 125 | MP0000653_abnormal_sex_gland | 0.72048887 |
| 126 | MP0002736_abnormal_nociception_after | 0.71838255 |
| 127 | MP0005395_other_phenotype | 0.71806147 |
| 128 | MP0000647_abnormal_sebaceous_gland | 0.71573556 |
| 129 | MP0005397_hematopoietic_system_phenotyp | 0.71150379 |
| 130 | MP0001545_abnormal_hematopoietic_system | 0.71150379 |
| 131 | MP0003937_abnormal_limbs/digits/tail_de | 0.71138594 |
| 132 | MP0002177_abnormal_outer_ear | 0.70668909 |
| 133 | MP0001346_abnormal_lacrimal_gland | 0.70346449 |
| 134 | MP0010368_abnormal_lymphatic_system | 0.70269731 |
| 135 | MP0004084_abnormal_cardiac_muscle | 0.70170172 |
| 136 | MP0005075_abnormal_melanosome_morpholog | 0.70166140 |
| 137 | MP0002234_abnormal_pharynx_morphology | 0.68999402 |
| 138 | MP0005410_abnormal_fertilization | 0.68415491 |
| 139 | MP0002282_abnormal_trachea_morphology | 0.67747536 |
| 140 | MP0002723_abnormal_immune_serum | 0.67300180 |
| 141 | MP0005501_abnormal_skin_physiology | 0.66001727 |
| 142 | MP0003938_abnormal_ear_development | 0.65518334 |
| 143 | MP0003984_embryonic_growth_retardation | 0.65517098 |
| 144 | MP0000689_abnormal_spleen_morphology | 0.64296752 |
| 145 | MP0002019_abnormal_tumor_incidence | 0.63615158 |
| 146 | MP0005220_abnormal_exocrine_pancreas | 0.63528240 |
| 147 | MP0002452_abnormal_antigen_presenting | 0.63527862 |
| 148 | MP0002405_respiratory_system_inflammati | 0.63521769 |
| 149 | MP0001485_abnormal_pinna_reflex | 0.63315785 |
| 150 | MP0001800_abnormal_humoral_immune | 0.62293863 |
| 151 | MP0002638_abnormal_pupillary_reflex | 0.62181825 |
| 152 | MP0002088_abnormal_embryonic_growth/wei | 0.61854841 |
| 153 | MP0003828_pulmonary_edema | 0.61556312 |
| 154 | MP0002429_abnormal_blood_cell | 0.61531130 |
| 155 | MP0000858_altered_metastatic_potential | 0.61296286 |
| 156 | MP0003763_abnormal_thymus_physiology | 0.60956950 |
| 157 | MP0005385_cardiovascular_system_phenoty | 0.60393167 |
| 158 | MP0001544_abnormal_cardiovascular_syste | 0.60393167 |
| 159 | MP0008873_increased_physiological_sensi | 0.58922378 |
| 160 | MP0002111_abnormal_tail_morphology | 0.58756547 |
| 161 | MP0002233_abnormal_nose_morphology | 0.58191050 |
| 162 | MP0001119_abnormal_female_reproductive | 0.55638058 |
| 163 | MP0005367_renal/urinary_system_phenotyp | 0.55399746 |
| 164 | MP0000516_abnormal_urinary_system | 0.55399746 |
| 165 | MP0003936_abnormal_reproductive_system | 0.55230236 |
| 166 | MP0000762_abnormal_tongue_morphology | 0.54685809 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hepatic necrosis (HP:0002605) | 4.80408777 |
| 2 | Acute necrotizing encephalopathy (HP:0006965) | 4.67214153 |
| 3 | Hepatocellular necrosis (HP:0001404) | 4.50756814 |
| 4 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.50290880 |
| 5 | Mitochondrial inheritance (HP:0001427) | 4.32738903 |
| 6 | Acute encephalopathy (HP:0006846) | 4.32050999 |
| 7 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 4.16826561 |
| 8 | Increased CSF lactate (HP:0002490) | 4.00534124 |
| 9 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.94352357 |
| 10 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.94352357 |
| 11 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.88693119 |
| 12 | Cerebral edema (HP:0002181) | 3.88065724 |
| 13 | Progressive macrocephaly (HP:0004481) | 3.68317439 |
| 14 | Cerebral palsy (HP:0100021) | 3.49251566 |
| 15 | Lactic acidosis (HP:0003128) | 3.35769364 |
| 16 | Increased serum lactate (HP:0002151) | 3.35734544 |
| 17 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.33803311 |
| 18 | Lipid accumulation in hepatocytes (HP:0006561) | 3.29477124 |
| 19 | Abnormal number of erythroid precursors (HP:0012131) | 3.26195048 |
| 20 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.23314764 |
| 21 | Increased hepatocellular lipid droplets (HP:0006565) | 3.21355956 |
| 22 | Generalized aminoaciduria (HP:0002909) | 3.19459431 |
| 23 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.18740393 |
| 24 | Increased intramyocellular lipid droplets (HP:0012240) | 3.17529962 |
| 25 | Nausea (HP:0002018) | 3.15151326 |
| 26 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.10580433 |
| 27 | Increased muscle lipid content (HP:0009058) | 3.10522256 |
| 28 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.02286739 |
| 29 | Dicarboxylic aciduria (HP:0003215) | 3.02286739 |
| 30 | Lethargy (HP:0001254) | 3.00065789 |
| 31 | Respiratory failure (HP:0002878) | 2.95141603 |
| 32 | Hypoglycemic coma (HP:0001325) | 2.95017565 |
| 33 | Exercise intolerance (HP:0003546) | 2.94324114 |
| 34 | Prolonged partial thromboplastin time (HP:0003645) | 2.92806533 |
| 35 | 3-Methylglutaconic aciduria (HP:0003535) | 2.87846351 |
| 36 | Hypobetalipoproteinemia (HP:0003563) | 2.83848154 |
| 37 | Hyperammonemia (HP:0001987) | 2.82130572 |
| 38 | Renal Fanconi syndrome (HP:0001994) | 2.81920361 |
| 39 | Reticulocytopenia (HP:0001896) | 2.79672241 |
| 40 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.74972488 |
| 41 | Abnormality of urine glucose concentration (HP:0011016) | 2.71977335 |
| 42 | Glycosuria (HP:0003076) | 2.71977335 |
| 43 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.65327315 |
| 44 | Exertional dyspnea (HP:0002875) | 2.61800308 |
| 45 | Intrahepatic cholestasis (HP:0001406) | 2.59706861 |
| 46 | Degeneration of anterior horn cells (HP:0002398) | 2.55757952 |
| 47 | Abnormality of the anterior horn cell (HP:0006802) | 2.55757952 |
| 48 | Hyperglycinuria (HP:0003108) | 2.53191131 |
| 49 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.52718906 |
| 50 | Abnormality of glycolysis (HP:0004366) | 2.52642711 |
| 51 | Increased serum pyruvate (HP:0003542) | 2.52642711 |
| 52 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.52549563 |
| 53 | Abnormality of alanine metabolism (HP:0010916) | 2.52549563 |
| 54 | Hyperalaninemia (HP:0003348) | 2.52549563 |
| 55 | Vomiting (HP:0002013) | 2.43836196 |
| 56 | Methylmalonic aciduria (HP:0012120) | 2.42482795 |
| 57 | Metabolic acidosis (HP:0001942) | 2.41815282 |
| 58 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.40871473 |
| 59 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.40871473 |
| 60 | Abnormal protein glycosylation (HP:0012346) | 2.40871473 |
| 61 | Abnormal glycosylation (HP:0012345) | 2.40871473 |
| 62 | CNS demyelination (HP:0007305) | 2.37906291 |
| 63 | Testicular atrophy (HP:0000029) | 2.37670575 |
| 64 | Paralysis (HP:0003470) | 2.37132127 |
| 65 | Sparse eyelashes (HP:0000653) | 2.35146648 |
| 66 | Xanthomatosis (HP:0000991) | 2.34419231 |
| 67 | Hyperglycinemia (HP:0002154) | 2.33988033 |
| 68 | Palpitations (HP:0001962) | 2.32570351 |
| 69 | Cerebral hypomyelination (HP:0006808) | 2.32342768 |
| 70 | Abnormality of renal resorption (HP:0011038) | 2.30493411 |
| 71 | Abnormality of serum amino acid levels (HP:0003112) | 2.28355026 |
| 72 | Macrocytic anemia (HP:0001972) | 2.26919601 |
| 73 | Pancytopenia (HP:0001876) | 2.26488414 |
| 74 | Rough bone trabeculation (HP:0100670) | 2.25104062 |
| 75 | Ragged-red muscle fibers (HP:0003200) | 2.23922236 |
| 76 | Joint hemorrhage (HP:0005261) | 2.23612640 |
| 77 | Deep venous thrombosis (HP:0002625) | 2.22668065 |
| 78 | Reduced antithrombin III activity (HP:0001976) | 2.21570139 |
| 79 | Ketosis (HP:0001946) | 2.20110240 |
| 80 | Microretrognathia (HP:0000308) | 2.18676950 |
| 81 | Respiratory difficulties (HP:0002880) | 2.18566791 |
| 82 | Multiple enchondromatosis (HP:0005701) | 2.18552845 |
| 83 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.18171279 |
| 84 | Abnormality of glycine metabolism (HP:0010895) | 2.18171279 |
| 85 | Hyperbilirubinemia (HP:0002904) | 2.17410020 |
| 86 | X-linked dominant inheritance (HP:0001423) | 2.17260383 |
| 87 | Abnormality of methionine metabolism (HP:0010901) | 2.16177042 |
| 88 | Microvesicular hepatic steatosis (HP:0001414) | 2.15490525 |
| 89 | Increased serum ferritin (HP:0003281) | 2.14810728 |
| 90 | Rhabdomyolysis (HP:0003201) | 2.14437378 |
| 91 | Proximal tubulopathy (HP:0000114) | 2.12987772 |
| 92 | Cleft eyelid (HP:0000625) | 2.12037380 |
| 93 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.11720784 |
| 94 | Emotional lability (HP:0000712) | 2.10317130 |
| 95 | Amniotic constriction ring (HP:0009775) | 2.09240404 |
| 96 | Abnormality of placental membranes (HP:0011409) | 2.09240404 |
| 97 | Hypercholesterolemia (HP:0003124) | 2.09110224 |
| 98 | Methylmalonic acidemia (HP:0002912) | 2.08920822 |
| 99 | Hypolipoproteinemia (HP:0010981) | 2.08602922 |
| 100 | Hyperlipoproteinemia (HP:0010980) | 2.05386623 |
| 101 | Meckel diverticulum (HP:0002245) | 2.04192931 |
| 102 | Delayed CNS myelination (HP:0002188) | 2.03474476 |
| 103 | Hypoplastic pelvis (HP:0008839) | 1.99853812 |
| 104 | Abnormality of the preputium (HP:0100587) | 1.99796930 |
| 105 | Type I transferrin isoform profile (HP:0003642) | 1.99501653 |
| 106 | Abnormality of iron homeostasis (HP:0011031) | 1.98649088 |
| 107 | Optic disc pallor (HP:0000543) | 1.97771920 |
| 108 | Aplastic anemia (HP:0001915) | 1.97210129 |
| 109 | Pallor (HP:0000980) | 1.96042040 |
| 110 | Progressive muscle weakness (HP:0003323) | 1.95242590 |
| 111 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.94853051 |
| 112 | Hyperphosphaturia (HP:0003109) | 1.93685132 |
| 113 | Abnormality of the ileum (HP:0001549) | 1.92153521 |
| 114 | Oral leukoplakia (HP:0002745) | 1.92148363 |
| 115 | Gliosis (HP:0002171) | 1.92137492 |
| 116 | Leukodystrophy (HP:0002415) | 1.90227606 |
| 117 | Abnormality of nucleobase metabolism (HP:0010932) | 1.89372832 |
| 118 | Blindness (HP:0000618) | 1.89115432 |
| 119 | Renal cortical cysts (HP:0000803) | 1.89087441 |
| 120 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.88609287 |
| 121 | Abnormality of the intrinsic pathway (HP:0010989) | 1.88518110 |
| 122 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.87670256 |
| 123 | Opisthotonus (HP:0002179) | 1.86986829 |
| 124 | Megaloblastic anemia (HP:0001889) | 1.86318130 |
| 125 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.86251695 |
| 126 | Myoglobinuria (HP:0002913) | 1.85725283 |
| 127 | Birth length less than 3rd percentile (HP:0003561) | 1.85676837 |
| 128 | Congenital, generalized hypertrichosis (HP:0004540) | 1.85295943 |
| 129 | Ketoacidosis (HP:0001993) | 1.84825146 |
| 130 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.84743959 |
| 131 | Absent thumb (HP:0009777) | 1.83642103 |
| 132 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.83365651 |
| 133 | Systemic lupus erythematosus (HP:0002725) | 1.83268892 |
| 134 | Brushfield spots (HP:0001088) | 1.82695209 |
| 135 | Conjunctival hamartoma (HP:0100780) | 1.81937090 |
| 136 | Facial cleft (HP:0002006) | 1.81612843 |
| 137 | Abnormal trabecular bone morphology (HP:0100671) | 1.76623570 |
| 138 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.70198630 |
| 139 | Horseshoe kidney (HP:0000085) | 1.70110593 |
| 140 | Secondary amenorrhea (HP:0000869) | 1.69869858 |
| 141 | Gout (HP:0001997) | 1.67790109 |
| 142 | Abnormal number of incisors (HP:0011064) | 1.66385245 |
| 143 | Progressive microcephaly (HP:0000253) | 1.65824558 |
| 144 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.64690050 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 4.98649558 |
| 2 | NME2 | 4.48219632 |
| 3 | BCKDK | 3.97528082 |
| 4 | BUB1 | 2.86457091 |
| 5 | EIF2AK1 | 2.80266253 |
| 6 | STK16 | 2.65722479 |
| 7 | PIM2 | 2.52202181 |
| 8 | CDC7 | 2.39775515 |
| 9 | PBK | 1.97742681 |
| 10 | IRAK3 | 1.95833883 |
| 11 | MAP3K11 | 1.91661419 |
| 12 | PDK2 | 1.88508618 |
| 13 | TLK1 | 1.85830326 |
| 14 | MYLK | 1.81450491 |
| 15 | EIF2AK3 | 1.77758916 |
| 16 | SRPK1 | 1.73180665 |
| 17 | MAP3K3 | 1.70515192 |
| 18 | NME1 | 1.67958662 |
| 19 | NEK9 | 1.66793767 |
| 20 | PLK3 | 1.61661267 |
| 21 | IRAK4 | 1.61346115 |
| 22 | KDR | 1.60388909 |
| 23 | OBSCN | 1.57569112 |
| 24 | PLK4 | 1.50644750 |
| 25 | MST1R | 1.48095970 |
| 26 | ERN1 | 1.47400930 |
| 27 | MAP2K3 | 1.46562626 |
| 28 | WEE1 | 1.45488141 |
| 29 | ZAK | 1.42800119 |
| 30 | TBK1 | 1.33159930 |
| 31 | ABL2 | 1.30158500 |
| 32 | TEC | 1.27560748 |
| 33 | FLT3 | 1.23960324 |
| 34 | VRK1 | 1.22525526 |
| 35 | TYK2 | 1.16889740 |
| 36 | STK38L | 1.15135998 |
| 37 | BRSK1 | 1.14305564 |
| 38 | MAP4K1 | 1.12733533 |
| 39 | PAK4 | 1.11453731 |
| 40 | TXK | 1.11053272 |
| 41 | ACVR1B | 1.10999184 |
| 42 | NEK1 | 1.10929655 |
| 43 | BRAF | 1.10776358 |
| 44 | RPS6KA4 | 1.08128610 |
| 45 | PIK3CG | 1.08015002 |
| 46 | IKBKB | 1.07773151 |
| 47 | KIT | 1.07422440 |
| 48 | TAOK2 | 1.05738763 |
| 49 | DYRK3 | 1.04092711 |
| 50 | EPHA2 | 1.02083980 |
| 51 | PIM1 | 1.01399583 |
| 52 | CSNK1G3 | 1.01251207 |
| 53 | TAF1 | 1.00768540 |
| 54 | ARAF | 1.00628477 |
| 55 | TESK1 | 0.96054888 |
| 56 | CDK8 | 0.95273509 |
| 57 | MUSK | 0.94858568 |
| 58 | TRIM28 | 0.94727846 |
| 59 | DYRK2 | 0.94306802 |
| 60 | CSNK1G1 | 0.92187070 |
| 61 | AURKB | 0.90294198 |
| 62 | ILK | 0.89107398 |
| 63 | MAP3K14 | 0.89007580 |
| 64 | TGFBR1 | 0.88584033 |
| 65 | SIK3 | 0.87057603 |
| 66 | PLK1 | 0.86634003 |
| 67 | DAPK1 | 0.86456846 |
| 68 | LRRK2 | 0.84302463 |
| 69 | MAP4K2 | 0.83499906 |
| 70 | IKBKE | 0.82171244 |
| 71 | MAPKAPK3 | 0.80329216 |
| 72 | TIE1 | 0.79684931 |
| 73 | EIF2AK2 | 0.78986983 |
| 74 | AURKA | 0.78779090 |
| 75 | STK4 | 0.76925615 |
| 76 | PINK1 | 0.75071998 |
| 77 | RPS6KB2 | 0.73393965 |
| 78 | MAP3K12 | 0.71424818 |
| 79 | CSNK1A1L | 0.70884510 |
| 80 | PRKCI | 0.70250428 |
| 81 | CSNK1G2 | 0.69332655 |
| 82 | STK24 | 0.68693012 |
| 83 | JAK3 | 0.68250470 |
| 84 | CSNK2A2 | 0.68075343 |
| 85 | BMPR1B | 0.67954138 |
| 86 | MAP2K7 | 0.66944898 |
| 87 | CCNB1 | 0.66827212 |
| 88 | WNK3 | 0.66358530 |
| 89 | DAPK3 | 0.64598500 |
| 90 | RPS6KA5 | 0.63921553 |
| 91 | BTK | 0.63756104 |
| 92 | ZAP70 | 0.62567522 |
| 93 | PAK1 | 0.61973147 |
| 94 | GRK1 | 0.61493565 |
| 95 | NEK2 | 0.60362545 |
| 96 | SCYL2 | 0.59844002 |
| 97 | CSNK2A1 | 0.59727238 |
| 98 | CHUK | 0.59557161 |
| 99 | PKN2 | 0.58650810 |
| 100 | TESK2 | 0.58349516 |
| 101 | LIMK1 | 0.57989617 |
| 102 | MAP3K5 | 0.57079793 |
| 103 | MAP3K8 | 0.55917144 |
| 104 | CHEK2 | 0.55762584 |
| 105 | TTK | 0.54357001 |
| 106 | CDK19 | 0.53304178 |
| 107 | STK10 | 0.52106339 |
| 108 | BLK | 0.51700738 |
| 109 | PHKG2 | 0.49891536 |
| 110 | PHKG1 | 0.49891536 |
| 111 | CHEK1 | 0.48805489 |
| 112 | BRSK2 | 0.48716885 |
| 113 | TAOK3 | 0.48613417 |
| 114 | MAPK11 | 0.48419969 |
| 115 | BMPR2 | 0.48081733 |
| 116 | ATR | 0.46990321 |
| 117 | MAP2K6 | 0.46522355 |
| 118 | MKNK1 | 0.45717461 |
| 119 | CDK4 | 0.45495984 |
| 120 | INSRR | 0.44737918 |
| 121 | PRKCD | 0.44410277 |
| 122 | PRKG2 | 0.44077062 |
| 123 | FGFR4 | 0.43802284 |
| 124 | MST4 | 0.43532496 |
| 125 | NUAK1 | 0.42230073 |
| 126 | MAP3K6 | 0.41895886 |
| 127 | MAP2K2 | 0.41889830 |
| 128 | CDK7 | 0.41412465 |
| 129 | SYK | 0.41219310 |
| 130 | TGFBR2 | 0.40497252 |
| 131 | ERBB4 | 0.40338298 |
| 132 | YES1 | 0.40189386 |
| 133 | TSSK6 | 0.38930950 |
| 134 | ADRBK2 | 0.36696124 |
| 135 | MKNK2 | 0.35757067 |
| 136 | ATM | 0.34834602 |
| 137 | TNIK | 0.33978529 |
| 138 | AKT2 | 0.29324704 |
| 139 | OXSR1 | 0.28283039 |
| 140 | MAPKAPK5 | 0.27366106 |
| 141 | CSNK1A1 | 0.25578703 |
| 142 | CSNK1E | 0.25380162 |
| 143 | CAMK2G | 0.24555194 |
| 144 | STK3 | 0.23105969 |
| 145 | PASK | 0.20724682 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Ribosome_Homo sapiens_hsa03010 | 3.25074788 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.80351542 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 2.77425965 |
| 4 | Parkinsons disease_Homo sapiens_hsa05012 | 2.61569185 |
| 5 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.47001073 |
| 6 | DNA replication_Homo sapiens_hsa03030 | 2.18460403 |
| 7 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.04569679 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.04437799 |
| 9 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.04437649 |
| 10 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.94172155 |
| 11 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.90039052 |
| 12 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.87201361 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.84632879 |
| 14 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.83429734 |
| 15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.82656621 |
| 16 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.81590598 |
| 17 | Huntingtons disease_Homo sapiens_hsa05016 | 1.77648098 |
| 18 | RNA polymerase_Homo sapiens_hsa03020 | 1.77459129 |
| 19 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.76012265 |
| 20 | Peroxisome_Homo sapiens_hsa04146 | 1.72164146 |
| 21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.70190239 |
| 22 | Alzheimers disease_Homo sapiens_hsa05010 | 1.65453204 |
| 23 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.65240038 |
| 24 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.65106179 |
| 25 | Mismatch repair_Homo sapiens_hsa03430 | 1.56146221 |
| 26 | Sulfur relay system_Homo sapiens_hsa04122 | 1.55460461 |
| 27 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.52857748 |
| 28 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.50227400 |
| 29 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.48220404 |
| 30 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.48061602 |
| 31 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.47263712 |
| 32 | Carbon metabolism_Homo sapiens_hsa01200 | 1.46333128 |
| 33 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.44064202 |
| 34 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.42378788 |
| 35 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.41456008 |
| 36 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.38150278 |
| 37 | Homologous recombination_Homo sapiens_hsa03440 | 1.30496245 |
| 38 | Base excision repair_Homo sapiens_hsa03410 | 1.29353247 |
| 39 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.28691446 |
| 40 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.28603243 |
| 41 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.28244263 |
| 42 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.22946729 |
| 43 | Protein export_Homo sapiens_hsa03060 | 1.22675151 |
| 44 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.22662901 |
| 45 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.19913279 |
| 46 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.19350480 |
| 47 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.18663426 |
| 48 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.18335457 |
| 49 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.17124715 |
| 50 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.12075680 |
| 51 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.09000565 |
| 52 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.06695008 |
| 53 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.05844157 |
| 54 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.04685504 |
| 55 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.04215607 |
| 56 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.03908871 |
| 57 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.02888881 |
| 58 | Retinol metabolism_Homo sapiens_hsa00830 | 1.01310498 |
| 59 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.01068104 |
| 60 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.99042795 |
| 61 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.95651786 |
| 62 | Histidine metabolism_Homo sapiens_hsa00340 | 0.95133940 |
| 63 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.92892932 |
| 64 | Spliceosome_Homo sapiens_hsa03040 | 0.92784596 |
| 65 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.92721824 |
| 66 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.92359354 |
| 67 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.91128516 |
| 68 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.89032259 |
| 69 | Metabolic pathways_Homo sapiens_hsa01100 | 0.86503759 |
| 70 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.84373805 |
| 71 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.83563521 |
| 72 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.82539107 |
| 73 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.79640437 |
| 74 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.79359265 |
| 75 | Galactose metabolism_Homo sapiens_hsa00052 | 0.79061764 |
| 76 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.77155141 |
| 77 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.72497457 |
| 78 | Purine metabolism_Homo sapiens_hsa00230 | 0.72399136 |
| 79 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.68581786 |
| 80 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.67308128 |
| 81 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.65009299 |
| 82 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.61123864 |
| 83 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.61106397 |
| 84 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.57688711 |
| 85 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.54260599 |
| 86 | RNA degradation_Homo sapiens_hsa03018 | 0.51027669 |
| 87 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.50940193 |
| 88 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.50007632 |
| 89 | RNA transport_Homo sapiens_hsa03013 | 0.47358748 |
| 90 | Legionellosis_Homo sapiens_hsa05134 | 0.44031928 |
| 91 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.42174617 |
| 92 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.41428974 |
| 93 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.40951046 |
| 94 | Cell cycle_Homo sapiens_hsa04110 | 0.40772890 |
| 95 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.40643560 |
| 96 | Basal transcription factors_Homo sapiens_hsa03022 | 0.38191327 |
| 97 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.36875320 |
| 98 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.36712956 |
| 99 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.36289461 |
| 100 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.34872283 |
| 101 | Other glycan degradation_Homo sapiens_hsa00511 | 0.34546372 |
| 102 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.33325632 |
| 103 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.32191541 |
| 104 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.30377394 |
| 105 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.29903378 |
| 106 | ABC transporters_Homo sapiens_hsa02010 | 0.29259526 |
| 107 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.29207938 |
| 108 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.28784736 |
| 109 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.28773757 |
| 110 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.26718098 |
| 111 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.24961116 |
| 112 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.24792787 |
| 113 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.24704566 |
| 114 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.23577819 |
| 115 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.22277635 |
| 116 | Mineral absorption_Homo sapiens_hsa04978 | 0.20847463 |

